Versant Venture Management, LLC / TPST
Versant Venture Management, LLC’s Tempest Therapeutics Inc Position
Does Versant Venture Management, LLC own Tempest Therapeutics Inc (TPST)? Not currently — the last reported position was 3.51M shares worth $3M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$3M
Q1 2025
Shares
3.51M
% of Portfolio
+4.30%
Quarters Held
1
position exited
Position History TPST
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 3.51M | $3M | +4.30% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versant Venture Management, LLC’s full portfolio or all institutional holders of TPST.